Víctor Cervera-Carrascón
PhD, VP of Business Development
Victor Cervera-Carrascón serves as the Vice President of Business Development, bringing a unique combination of scientific expertise and strategic insight to the role. With a focus on immunotherapy and the development of oncolytic viruses to enhance T-cell responses and immune checkpoint blockade, Victor plays a pivotal role in advancing the company’s mission.
In his capacity, Victor holds key business development functions focused on strategic partnerships. Leveraging his scientific background, he works towards seamless integration of innovative approaches into business strategies.
